4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-23-000020
Director sold 20,000 shares at $28.62 ($572,400)
- Director acquired 20,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Schenkein David P · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2023-02-13 | Exercise or conversion : show line 1 in the form | +20,000 | $9.05 | $181,000 | 137,879 | D |
| 2023-02-13 | Sale : show line 2 in the form | −20,000 | $28.62 | $572,400 | 117,879 | D |
| Open-market sales · 20,000 sh · avg $28.62 · $572,400 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2023-02-13 | Exercise or conversion : show line 3 in the form Stock option (right to buy) | −20,000 | 76,363 | D |
Loading xslF345X03/wf-form4_167649497047928.xml…